AkzoNobel stock faces UK merger test after EU clearance
Published on 11/12/2026 at 17:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMerger remedy becomes central
- The UK review found competition concerns limited to vehicle refinish coatings.
- AkzoNobel and Axalta plan to use the remedy package agreed with the European Commission.
- The companies continue to target completion of the merger in early 2027.
AkzoNobel and Axalta face a new regulatory hurdle after the UK Competition and Markets Authority's Phase 1 review of their planned merger. In a media release dated Wednesday, November 11, AkzoNobel said the CMA's concerns relate solely to vehicle refinish coatings in the UK.
The companies aim to address the issue with the same remedy proposal included in the European Commission's conditional clearance. That package involves the divestment of AkzoNobel's European vehicle refinish coatings business, including its UK operations, according to AkzoNobel.
What changes for the transaction
The regulatory focus now shifts from the European clearance to the execution of the proposed remedy in the UK. AkzoNobel and Axalta said they will continue engaging with both regulators and remain confident that the merger can be completed in early 2027.
The companies say the combination would create a global coatings group with approximately 17 billion US dollars in revenue. The transaction has not closed, so the planned portfolio benefits remain subject to regulatory and other closing conditions.
AkzoNobel stock traded at 63.48 euros on Lang & Schwarz at 17:11 CET on Thursday, November 12, 2026.
AkzoNobel at a glance
- Company: Akzo Nobel N.V.
- ISIN: NL0013267909
- Trading venue: Lang & Schwarz
- Price: 63.48 euros at 17:11 CET on November 12, 2026
European coating-sector shares remain sensitive to merger approvals, remedy requirements and execution risk. See current AEX market coverage for the broader Dutch market environment.
